Transthyretin oligomers induce calcium influx via voltage-gated calcium channels

Journal of Neurochemistry

Volumn 100, Issue 2, 2007, Pages 446-457

  Hou, Xu ^a   Parkington, Helena C ^a   Coleman, Harold A ^a   Mechler, Adam ^a   Martin, Lisandra L ^a   Aguilar, Marie Isabel ^a   Small, David H ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Amyloid; Atomic force microscopy; Fura 2; Oligomers; Transthyretin; Voltage gated calcium channels

Indexed keywords

CALCIUM; CALCIUM CHANNEL N TYPE; OLIGOMER; PREALBUMIN; VOLTAGE GATED CALCIUM CHANNEL;

ARTICLE; ATOMIC FORCE MICROSCOPY; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CONTROLLED STUDY; CYTOTOXICITY; EXTRACELLULAR CALCIUM; FIBER; HOMEOSTASIS; HUMAN; HUMAN CELL; LIGHT SCATTERING; MOLECULAR WEIGHT; NEUROBLASTOMA CELL; POLYMERIZATION; PRIORITY JOURNAL; PROTEIN AGGREGATION; TURBIDITY;

CALCIUM; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ENZYME INHIBITORS; EXTRACELLULAR FLUID; FURA-2; HUMANS; MICROSCOPY, ATOMIC FORCE; MUTATION; NEUROBLASTOMA; PREALBUMIN; PROTEIN STRUCTURE, QUATERNARY; THAPSIGARGIN; TIME FACTORS; TRANSFECTION;

EID: 33845786470     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2006.04210.x     Document Type: Article

References (69)

1. Andrade C. (1952) A peculiar form of peripheral neuropathy; familiar atypical generalized amyloidosis with special involvement of the peripheral nerves. Brain 75, 408-427.
2. Bernheimer A. W. and Rudy B. (1986) Interactions between membranes and cytolytic peptides. Biochim. Biophys. Acta 864, 123-141.
3. Berridge M. J., Bootman M. D. and Lipp P. (1998) Calcium - a life and death signal. Nature 395, 645-648.
4. Bhattacharyya A. M., Thakur A. K. and Wetzel R. (2005) Polyglutamine aggregation nucleation: thermodynamics of a highly unfavorable protein folding reaction. Proc. Natl Acad. Sci. USA 102, 15 400-15 405.
5. Bitan G., Lomakin A. and Teplow D. B. (2001) Amyloid β-protein oligomerization: prenucleation interactions revealed by photo-induced cross-linking of unmodified proteins. J. Biol. Chem. 276, 35 176-35 184.
6. Blake C. C., Geisow M. J., Swan I. D., Rerat C. and Rerat B. (1974) Structure of human plasma prealbumin at 2-5 Å resolution. A preliminary report on the polypeptide chain conformation, quaternary structure and thyroxine binding. J. Mol. Biol. 88, 1-12.
7. Blake C. C., Geisow M. J., Oatley S. J., Rerat B. and Rerat C. (1978) Structure of prealbumin: secondary, tertiary and quaternary interactions determined by Fourier refinement at 1.8 Å. J. Mol. Biol. 121, 339-356.
8. Bonnet N. S., Vautrot D. P. and Troyon M. (1994) A mathematical morphology approach to image-formation and image-restoration in scanning tunneling and atomic-force microscopies. Microsc. Microanal. Microstruct. 5, 477-487.
9. Bucciantini M., Calloni G., Chiti F., Formigli L., Nosi D., Dobson C. M. and Stefani M. (2004) Prefibrillar amyloid protein aggregates share common features of cytotoxicity. J. Biol. Chem. 279, 31 374-31 382.
10. 2+, and arterial smooth muscle relaxation. Am. J. Physiol. 263, C468-C473.
11. Connors L. H., Lim A., Prokaeva T., Roskens V. A. and Costello C. E. (2003) Tabulation of human transthyretin (TTR) variants, 2003. Amyloid 10, 160-184.
12. Costa P. P., Figueira A. S. and Bravo F. R. (1978) Amyloid fibril protein related to prealbumin in familial amyloidotic polyneuropathy. Proc. Natl Acad. Sci. USA 75, 4499-4503.
13. Demuro A., Mina E., Kayed R., Milton S. C., Parker I. and Glabe C. G. (2005) Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers. J. Biol. Chem. 280, 17 294-17 300.
14. Florio T., Grimaldi M., Scorziello A., Salmona M., Bugiani O., Tagliavini F., Forloni G. and Schettini G. (1996) Intracellular calcium rise through L-type calcium channels, as molecular mechanism for prion protein fragment 106-126-induced astroglial proliferation. Biochem. Biophys. Res. Commun. 228, 397-405.
15. Hammarstrom P., Jiang X., Hurshman A. R., Powers E. T. and Kelly J. W. (2002) Sequence-dependent denaturation energetics: a major determinant in amyloid disease diversity. Proc. Natl Acad. Sci. USA 99, 16 427-16 432.
16. Herms J. W., Korte S., Gall S., Schneider I., Dunker S. and Kretzschmar H. A. (2000) Altered intracellular calcium homeostasis in cerebellar granule cells of prion protein-deficient mice. J. Neurochem. 75, 1487-1492.
17. Ho R., Ortiz D. and Shea T. B. (2001) Amyloid-β promotes calcium influx and neurodegeneration via stimulation of L voltage-sensitive calcium channels rather than NMDA channels in cultured neurons. J. Alzheimers Dis. 3, 479-483.
18. Hou X., Richardson S. J., Aguilar M. I. and Small D. H. (2005) Binding of amyloidogenic transthyretin to the plasma membrane alters membrane fluidity and induces neurotoxicity. Biochemistry 44, 11 618-11 627.
19. Hugel B., Martinez M. C., Kunzelmann C., Blattler T., Aguzzi A. and Freyssinet J. M. (2004) Modulation of signal transduction through the cellular prion protein is linked to its incorporation in lipid rafts. Cell. Mol. Life Sci. 61, 2998-3007.
20. Hurshman A. R., White J. T., Powers E. T. and Kelly J. W. (2004) Transthyretin aggregation under partially denaturing conditions is a downhill polymerization. Biochemistry 43, 7365-7381.
21. Jacobson D. R., McFarlin D. E., Kane I. and Buxbaum J. N. (1992) Transthyretin Pro55, a variant associated with early-onset, aggressive, diffuse amyloidosis with cardiac and neurologic involvement. Hum. Genet. 89, 353-356.
22. Kindzelskii A. L., Sitrin R. G. and Petty H. R. (2004) Cutting edge: optical microspectrophotometry supports the existence of gel phase lipid rafts at the lamellipodium of neutrophils: apparent role in calcium signaling. J. Immunol. 172, 4681-4685.
23. 2+ of agonist-stimulated divalent cation entry from the refilling of the agonist-sensitive intracellular pool. J. Biol. Chem. 265, 678-684.
24. Ladokhin A. S., Selsted M. E. and White S. H. (1997) Sizing membrane pores in lipid vesicles by leakage of co-encapsulated markers: pore formation by melittin. Biophys. J. 72, 1762-1766.
25. LaFerla F. M. (2002) Calcium dyshomeostasis and intracellular signalling in Alzheimer's disease. Nat. Rev. Neurosci. 3, 862-872.
26. Lai Z., Colon W. and Kelly J. W. (1996) The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid. Biochemistry 35, 6470-6482.
27. 1-42 are potent central nervous system neurotoxins. Proc. Natl Acad. Sci. USA 95, 6448-6453.
28. Lashuel H. A., Hartley D., Petre B. M., Wal Z. T. and Lansbury P. T. Jr (2002) Neurodegenerative disease: amyloid pores from pathogenic mutations. Nature 418, 291.
29. Li H., Ayer L. M., Polyak M. J. et al. (2004) The CD20 calcium channel is localized to microvilli and constitutively associated with membrane rafts: antibody binding increases the affinity of the association through an epitope-dependent cross-linking-independent mechanism. J. Biol. Chem. 279, 19 893-19 901.
30. Lin H., Bhatia R. and Lal R. (2001) Amyloid β protein forms ion channels: implications for Alzheimer's disease pathophysiology. FASEB J. 15, 2433-2444.
31. Lin K. F., Chang R. C., Suen K. C., So K. F. and Hugon J. (2004) Modulation of calcium/calmodulin kinase-II provides partial neuroprotection against β-amyloid peptide toxicity. Eur. J. Neurosci. 19, 2047-2055.
32. Lomakin A., Teplow D. B., Kirschner D. A. and Benedek G. B. (1997) Kinetic theory of fibrillogenesis of amyloid β-protein. Proc. Natl Acad. Sci. USA 94, 7942-7947.
33. 2+ channel activity by β-amyloid-(1-40) in rat cortical synaptosomes and cultured cortical neurons. Modulation by the proinflammatory cytokine interleukin-1beta. J. Biol. Chem. 275, 4713-4718.
34. Mattson M. P. (2004) Pathways towards and away from Alzheimer's disease. Nature 430, 631-639.
35. Mattson M. P. and Chan S. L. (2003) Calcium orchestrates apoptosis. Nat. Cell Biol. 5, 1041-1043.
36. Mattson M. P., Cheng B., Davis D., Bryant K., Lieberburg I. and Rydel R. E. (1992) β-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J. Neurosci. 12, 376-389.
37. McLaurin J. and Chakrabartty A. (1996) Membrane disruption by Alzheimer β-amyloid peptides mediated through specific binding to either phospholipids or gangliosides. Implications for neurotoxicity. J. Biol. Chem. 271, 26 482-26 489.
38. Merritt J. E., Armstrong W. P., Benham C. D. et al. (1990) SK & F 96365, a novel inhibitor of receptor-mediated calcium entry. Biochem. J. 271, 515-522.
39. 2+ influx into parotid acini. J. Biol. Chem. 265, 15 010-15 014.
40. Molander-Melin M., Blennow K., Bogdanovic N., Dellheden B., Mansson J. E. and Fredman P. (2005) Structural membrane alterations in Alzheimer brains found to be associated with regional disease development; increased density of gangliosides GM1 and GM2 and loss of cholesterol in detergent-resistant membrane domains. J. Neurochem. 92, 171-182.
41. Monteiro F. A., Sousa M. M., Cardoso I., do Amaral J. B., Guimaraes A. and Saraiva M. J. (2006) Activation of ERK1/2 MAP kinases in familial amyloidotic polyneuropathy. J. Neurochem. 97, 151-161.
42. Murphy R. M. (2002) Peptide aggregation in neurodegenerative disease. Annu. Rev. Biomed. Eng. 4, 155-174.
43. Nguyen H. D. and Hall C. K. (2005) Kinetics of fibril formation by polyalanine peptides. J. Biol. Chem. 280, 9074-9082.
44. Noble K., Zhang J. and Wray S. (2006) Lipid rafts, the sarcoplasmic reticulum and uterine calcium signalling: an integrated approach. J. Physiol. 570, 29-35.
45. O'Connell K. M., Martens J. R. and Tamkun M. M. (2004) Localization of ion channels to lipid raft domains within the cardiovascular system. Trends Cardiovasc. Med. 14, 37-42.
46. Olofsson A., Ostman J. and Lundgren E. (2002) Amyloid: morphology and toxicity. Clin. Chem. Lab. Med. 40, 1266-1270.
47. Peterson C. and Goldman J. E. (1986) Alterations in calcium content and biochemical processes in cultured skin fibroblasts from aged and Alzheimer donors. Proc. Natl Acad. Sci. USA 83, 2758-2762.
48. Quintas A., Saraiva M. J. and Brito R. M. (1997) The amyloidogenic potential of transthyretin variants correlates with their tendency to aggregate in solution. FEBS Lett. 418, 297-300.
49. Quist A., Doudevski I., Lin H., Azimova R., Ng D., Frangione B., Kagan B., Ghiso J. and Lal R. (2005) Amyloid ion channels: a common structural link for protein-misfolding disease. Proc. Natl Acad. Sci. USA 102, 10 427-10 432.
50. Reixach N., Deechongkit S., Jiang X., Kelly J. W. and Buxbaum J. N. (2004) Tissue damage in the amyloidoses: transthyretin monomers and nonnative oligomers are the major cytotoxic species in tissue culture. Proc. Natl Acad. Sci. USA 101, 2817-2822.
51. 2+-sensitive channel. J. Biol. Chem. 273, 13 379-13 382.
52. Saraiva M. J., Birken S., Costa P. P. and Goodman D. S. (1984) Amyloid fibril protein in familial amyloidotic polyneuropathy, Portuguese type. Definition of molecular abnormality in transthyretin (prealbumin). J. Clin. Invest. 74, 104-119.
53. Schreiber G. and Richardson S. J. (1997) The evolution of gene expression, structure and function of transthyretin. Comp. Biochem. Physiol. B Biochem. Mol. Biol. 116, 137-160.
54. Schwarz G., Zong R. T. and Popescu T. (1992) Kinetics of melittin induced pore formation in the membrane of lipid vesicles. Biochim. Biophys. Acta 1110, 97-104.
55. Simons K. and Toomre D. (2000) Lipid rafts and signal transduction. Nat. Rev. Mol. Cell Biol. 1, 31-39.
56. 2+ signaling leading to nitric oxide production and endothelial cell adhesion and proliferation. Exp. Cell Res. 295, 102-118.
57. Small D. H., Mok S. S. and Bornstein J. C. (2001) Alzheimer's disease and Ab toxicity: from top to bottom. Nat. Rev. Neurosci. 2, 595-598.
58. Sousa M. M., Du Yan S., Fernandes R., Guimaraes A., Stern D. and Saraiva M. J. (2001) Familial amyloid polyneuropathy: receptor for advanced glycation end products-dependent triggering of neuronal inflammatory and apoptotic pathways. J. Neurosci. 21, 7576-7586.
59. c capping in T cells promotes its association with the lipid raft proteins reggie-1 and reggie-2 and leads to signal transduction. FASEB J. 18, 1731-1733.
60. Suen K. C., Lin K. F., Elyaman W., So K. F., Chang R. C. and Hugon J. (2003) Reduction of calcium release from the endoplasmic reticulum could only provide partial neuroprotection against β-amyloid peptide toxicity. J. Neurochem. 87, 1413-1426.
61. Suzuki K. (1976) Chemistry and metabolism of brain lipids, in Basic Neurochemistry, 2nd edn (Siegel G. J., Albers R. W., Katzman R. and Agranoff B. W., eds), pp. 308-328. Little, Brown, Boston.
62. Teixeira P. F., Cerca F., Santos S. D. and Saraiva M. J. (2006) Endoplasmic reticulum stress associated with extracellular aggregates: evidence from transthyretin deposition in familial amyloid polyneuropathy. J. Biol. Chem. 281, 21 998-22 003.
63. Thellung S., Florio T., Corsaro A. et al. (2000) Intracellular mechanisms mediating the neuronal death and astrogliosis induced by the prion protein fragment 106-126. Int. J. Dev. Neurosci. 18, 481-492.
64. Thirumalai D., Klimov D. K. and Dima R. I. (2003) Emerging ideas on the molecular basis of protein and peptide aggregation. Curr. Opin. Struct. Biol. 13, 146-159.
65. 2+ channels: a possible involvement of free radicals. J. Neurochem. 68, 265-271.
66. Unruh T. L., Li H., Mutch C. M., Shariat N., Grigoriou L., Sanyal R., Brown C. B. and Deans J. P. (2005) Cholesterol depletion inhibits src family kinase-dependent calcium mobilization and apoptosis induced by rituximab crosslinking. Immunology 116, 223-232.
67. Walsh D. M., Klyubin I., Fadeeva J. V., Rowan M. J. and Selkoe D. J. (2002) Amyloid-β oligomers: their production, toxicity and therapeutic inhibition. Biochem. Soc. Trans. 30, 552-557.
68. Yagami T., Ueda K., Sakaeda T., Itoh N., Sakaguchi G., Okamura N., Hori Y. and Fujimoto M. (2004) Protective effects of a selective L-type voltage-sensitive calcium channel blocker, S-312-d, on neuronal cell death. Biochem. Pharmacol. 67, 1153-1165.
69. Zhou X. and Arthur G. (1992) Improved procedures for the determination of lipid phosphorus by malachite green. J. Lipid Res. 33, 1233-1236.